Investing.com - Stryker (NYSE:SYK) reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Stryker announced earnings per share of $2.2 on revenue of $4.16B. Analysts polled by Investing.com anticipated EPS of $2.29 on revenue of $4.23B.
Stryker shares are down 2% from the beginning of the year, still down 4.51% from its 52 week high of $281.16 set on September 9. They are under-performing the S&P 500 which is up 22.37% from the start of the year.
Stryker shares lost 3.16% in after-hours trade following the report.
Stryker follows other major Healthcare sector earnings this month
Stryker's report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar